Upcoming Investor Events and Conferences

Summary by AI ^BETAClose X

Oxford Nanopore Technologies plc announced its participation in two upcoming investor conferences in March. The company will attend the Barclays 28th Annual Global Healthcare Conference in Miami on March 11th, featuring an analyst-led fireside chat and investor meetings, with a webcast available. Additionally, Oxford Nanopore will participate in the Berenberg UK Corporate Conference in Hertfordshire on March 17th, also including an analyst-led fireside chat and investor meetings.

Disclaimer*

Oxford Nanopore Technologies plc

04 March 2026

Oxford Nanopore Technologies plc

("Oxford Nanopore" or the "Company")

Oxford Nanopore to participate in upcoming investor conferences

04 March 2026

Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in March.

· Barclays 28^th Annual Global Healthcare Conference, Miami

Format: Analyst led fireside chat and one-on-one and group investor meetings

Date: Wednesday, 11 March

Time: 3:30pm ET (7:30pm GMT)

Webcast: click here to register

· Berenberg UK Corporate Conference, Hertfordshire

Format: Analyst led fireside chat and one-on-one and group investor meetings

Date: Tuesday, 17 March

A live webcast of the Barclays conference can be accessed at the Company's investor relations page at: https://nanoporetech.com/about/investors/reports. A webcast replay will be available for at least 30 days following the event via the same link.

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors: ir@nanoporetech.com

Media: media@nanoporetech.com

Teneo (communications adviser to the Company)

Tom Murray, Lisa Jarrett-Kerr

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END